Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma

Gamma-glutamyltransferase (GGT) is an established marker for proliferative/apoptotic balance and has been associated with cancer risk and prognosis. The aim of this study was to evaluate the value of pre-treatment GGT serum levels as prognostic biomarker in patients with primary uterine leiomyosarco...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwameis, Richard, Grimm, Christoph, Brodowicz, Thomas, Petru, Edgar, Hefler-Frischmuth, Katrin, Staudigl, Christine, Reinthaller, Alexander, Heinze, Georg, Polterauer, Stephan, Polterauer, Mariella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028736/
https://www.ncbi.nlm.nih.gov/pubmed/27646551
http://dx.doi.org/10.1038/srep33757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028736/
https://www.ncbi.nlm.nih.gov/pubmed/27646551
http://dx.doi.org/10.1038/srep33757

Ejemplares similares